# Roche completes acquisition of LumiraDx's Point of Care technology

Roche completed the acquisition of LumiraDx's Point of Care technology after receiving all regulatory clearances, integrating the multi-assay platform into its diagnostics portfolio.

- Type: Acquisition
- Announced: 2024-07-29
- Status: completed
- Products: point of care diagnostic platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Roche Holdings Inc](https://endata.com/companies/16415.md) (acquirer)
- [LumiraDx](https://endata.com/companies/74713.md) (target)

## Sources

- [roche.com](https://www.roche.com/media/releases/med-cor-2024-07-29), 2024-07-29: "Access to diagnostic testing is critical for the delivery of healthcare worldwide and we are confident that the LumiraDx platform and technology will help us expand the availability of testing."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.